Although NPM1 mutations are typically associated with favorable long-term prognosis, in the context of acute coagulopathy, they are often associated with high tumor burden, rapid cell turnover, and hyperleukocytosis (particularly when co-mutated with FLT3), thereby contributing to a pro-coagulant state [26]. The gene discussed is NPM1; the disease is neoplasm.